MacroGenics, Inc.
NASDAQ:MGNX
3.3 (USD) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 58.749 | 151.941 | 75.643 | 97.764 | 62.024 | 60.121 | 155.516 | 86.582 | 100.854 | 47.264 | 56.753 | 59.646 | 47.054 |
| Cost of Revenue
| 17.867 | 7.384 | 2.651 | 193.201 | 195.309 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| 40.882 | 144.557 | 72.992 | -95.437 | -133.285 | 60.121 | 155.516 | 86.582 | 100.854 | 47.264 | 56.753 | 59.646 | 47.054 |
| Gross Profit Ratio
| 0.696 | 0.951 | 0.965 | -0.976 | -2.149 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Reseach & Development Expenses
| 156.938 | 207.026 | 214.577 | 193.201 | 195.309 | 190.827 | 147.232 | 122.091 | 98.271 | 70.186 | 46.582 | 45.433 | 41.089 |
| General & Administrative Expenses
| 0 | 0 | 0 | 42.742 | 46.064 | 40.5 | 32.653 | 29.831 | 22.765 | 15.926 | 11.087 | 10.188 | 10.869 |
| Selling & Marketing Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 52.188 | 58.949 | 63.014 | 42.742 | 46.064 | 40.5 | 32.653 | 29.831 | 22.765 | 15.926 | 11.087 | 10.188 | 10.869 |
| Other Expenses
| 7.603 | 1.66 | -1.804 | -7.119 | -2.164 | -0.247 | 2.517 | 1.514 | 0.042 | 0.002 | -0.627 | 0.151 | 1.467 |
| Operating Expenses
| 209.126 | 265.975 | 275.787 | 228.824 | 239.209 | 231.327 | 177.659 | 146.624 | 121.036 | 85.579 | 56.387 | 51.441 | 41.805 |
| Operating Income
| -168.244 | -121.418 | -202.795 | -131.06 | -177.185 | -171.206 | -22.143 | -60.042 | -20.182 | -38.315 | 0.366 | 8.205 | 5.25 |
| Operating Income Ratio
| -2.864 | -0.799 | -2.681 | -1.341 | -2.857 | -2.848 | -0.142 | -0.693 | -0.2 | -0.811 | 0.006 | 0.138 | 0.112 |
| Total Other Income Expenses Net
| 159.186 | 1.66 | 0.68 | 1.321 | 25.374 | -0.247 | 2.517 | 1.514 | 0.042 | 0.002 | -0.627 | 0.151 | 1.467 |
| Income Before Tax
| -9.058 | -119.758 | -202.115 | -129.739 | -151.811 | -171.453 | -19.626 | -58.528 | -20.14 | -38.313 | -0.261 | 8.362 | 6.717 |
| Income Before Tax Ratio
| -0.154 | -0.788 | -2.672 | -1.327 | -2.448 | -2.852 | -0.126 | -0.676 | -0.2 | -0.811 | -0.005 | 0.14 | 0.143 |
| Income Tax Expense
| 9.477 | 0.263 | -11.258 | -11.957 | 10.673 | -0.247 | -7.228 | -7.608 | 0 | -1.822 | 0 | -0.006 | 0 |
| Net Income
| -9.058 | -120.021 | -190.857 | -117.782 | -151.811 | -171.453 | -19.626 | -58.528 | -20.14 | -38.313 | -0.261 | 8.362 | 6.717 |
| Net Income Ratio
| -0.154 | -0.79 | -2.523 | -1.205 | -2.448 | -2.852 | -0.126 | -0.676 | -0.2 | -0.811 | -0.005 | 0.14 | 0.143 |
| EPS
| -0.15 | -1.95 | -3.18 | -2.25 | -3.16 | -4.19 | -0.54 | -1.69 | -0.63 | -1.4 | -0.04 | 0.46 | 0.37 |
| EPS Diluted
| -0.15 | -1.95 | -3.18 | -2.25 | -3.16 | -4.19 | -0.54 | -1.69 | -0.63 | -1.4 | -0.038 | 0.46 | 0.37 |
| EBITDA
| -158.599 | -121.418 | -202.795 | -131.06 | -166.34 | -162.927 | -22.143 | -60.042 | -17.319 | -38.315 | 1.559 | 9.165 | 6.397 |
| EBITDA Ratio
| -2.7 | -0.799 | -2.681 | -1.341 | -2.682 | -2.71 | -0.142 | -0.693 | -0.172 | -0.811 | 0.027 | 0.154 | 0.136 |